We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EBIO: Epoch Pharmaceuticals

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (17)9/18/2002 5:27:10 AM
From: mopgcw  Read Replies (1) of 33
Epoch Biosciences Insider Bought 94,505 Shares Thu-Fri


WASHINGTON -- Epoch Biosciences Inc. (EBIO) insider Bradford T. Whitmore purchased 94,505 shares of the company's common stock Thursday and Friday, according to a Form 4 released Tuesday by the Securities and Exchange Commission.

Whitmore bought the shares for $1.12 and $1.15 a share. He directly owns 521,819 common shares and indirectly owns 5 million common shares.

Redmond, Wash.-based Epoch Biosciences develops and makes chemistry with commercial applications in the fields of genomics and molecular diagnostics.

Shares of the company recently traded at $1.14, down 5 cents or 4.6%.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext